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Abstract
Meta-analysis, because of both logistical convenience and statistical efficiency, is widely popular for synthesizing
information on common parameters of interest across multiple studies. We propose developing a generalized
meta-analysis approach for combining information on multivariate regression parameters across multiple different
studies which have varying level of covariate information. Using algebraic relationships between regression
parameters in different dimensions, we specify a set of moment equations for estimating parameters of a maximal
model through information available from sets of parameter estimates from a series of reduced models available
from the different studies. The specification of the equations requires a reference dataset to estimate the joint
distribution of the covariates. We propose to solve these equations using the generalized method of moments
approach, with the optimal weighting of the equations taking into account uncertainty associated with estimates
of the parameters of the reduced models. We describe extensions of the iterated reweighted least square algorithm
for fitting generalized linear regression models using the proposed framework. Based on the same moment
equations, we also propose a diagnostic test for detecting violation of underlying model assumptions, such as
those arising due to heterogeneity in the underlying study populations. Methods are illustrated using extensive
simulation studies and a real data example involving the development of a breast cancer risk prediction model
using disparate risk factor information from multiple studies.
Keywords: Data Integration; Empirical Likelihood; Generalized Method of Moments; Meta-Analysis; Missing Data;
Semiparametric Inference.
1 Introduction
In a variety of domains of applications, including observational epidemiologic studies, clinical trials and modern
genome-wide association studies, meta-analysis is widely used to synthesize information on underlying common
parameters of interest across multiple studies (Dersimonian & Laird, 1986, 2015; Ioannidis, 2005; Kavvoura &
Ioannidis, 2008). The popularity of meta-analysis stems from the fact that it can be performed based only on
estimates of model parameters and standard errors, avoiding various logistical, ethical and privacy concerns associated
with accessing the individual level data that is required in pooled analysis. Moreover, in many common settings, it
can be shown that under reasonable assumptions, meta-analyzed estimates of model parameters are asymptotically
as efficient as those from pooled analysis (Olkin & Sampson, 1998; Mathew & Nordstrom, 1999; Lin & Zeng, 2010).
In fact, meta-analysis approaches are now being used in divide and conquer approaches to big data, even when
individual level data are potentially available, because of the daunting computational task of model fitting with
extremely large sample sizes (Jordan, 2013; Fan et al. , 2014; Chun et al. , 2015).
In this article, we study the problem of multivariate meta-analysis in the setting of parametric regression
modeling of an outcome given a set of covariates. In standard settings, if estimates of multivariate parameters
for an underlying common regression model and associated covariances are available across all the studies, then
meta-analysis can be performed by taking inverse-variance-covariance weighted average of the vector of regression
coefficients (van Houwelingen et al. , 2002; Ritz et al. , 2008; Jackson et al. , 2011). In many applications, a typical
problem is that different studies include different, but possibly overlapping, sets of covariates. In a large consortium
of epidemiologic studies, for example, some key risk factors will be measured across all the studies. Inevitably,
however, there will be potentially important covariates which are measured only in some, but not all the studies. It
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is also possible that some covariates are measured at a more detailed level or with a finer instrument in some studies
compared to others. Disparate sets of covariates across studies render standard meta-analysis to be applicable for
the development of models only limited to a core set of variables that are measured in the same fashion across all
the studies.
We propose a generalized meta-analysis (GENMETA) approach for building rich models using information on
model parameters across studies with disparate covariate information. GENMETA is built upon a fundamental
mathematical relationship between parameters of two regression models in different dimensions from our recent
study (Chatterjee et al. , 2016). In the current article, we utilize this mathematical relationship to develop a
general framework for combining information on parameters of various models of different dimensions within the
generalized method of moments framework (Hansen, 1982; Imbens, 2002). We develop an iterated reweighted least
square algorithm allowing stable and speedy computation of estimates. The proposed method requires access to a
reference dataset for estimating of joint distribution of the covariates in a nonparametric fashion. We show how the
reference dataset can be used to derive an optimal estimator and associated variance-covariances even when entire
variance-covariance matrices for model parameter estimates may not be obtainable from individual studies.
2 Models and Methods
2.1 Model Formulation
Suppose we have parameter estimates θˆk and associated estimates of their covariance matrices Sk fromK independent
studies which have fitted reduced regression models, for which the likelihood is of the form gk(Y |XAk ; θk), where
Y is a common underlying outcome of interest but the vector of covariates XAk is potentially distinct across the
studies. Let X be the set of covariates used across all studies and we assume the true distribution of Y given X can
be specified by a maximal regression model f(Y |X;β). Our goal is to estimate and make inference about β∗, the
true value of β, based on summary-level information, (θˆk, Sk) from the K studies.
In the proposed setup, it is possible but not necessary, that one or more of the studies have information on
all covariates to fit the maximal model by themselves. Under certain study designs, such as the multi-phase
designs (Breslow & Cain, 1988; Breslow & Holubkov, 1997; Whittemore, 1997; Scott & Wild, 1997) and the partial
questionnaire design (Wacholder & Carroll, 1994), data could be partitioned into independent sets where the maximal
model can be fitted on some sets and various reduced models can be fitted on others. The maximal model f(Y |X;β)
and the reduced models gk(Y |XAk ; θk) may have different parametric forms, such as logistic and probit models
when Y is a binary disease outcome. This setup also allows incorporation of covariates which may be measured
more accurately or in a more refined fashion in some studies than others. For example, different studies may include
two types of measurements, namely, Z1 and Z2, for the same covariate, with Z2 a more refined measurement. In
this case the different reduced models may include Z1 or Z2, but we require that the reference dataset includes both
Z1 and Z2. In the maximal model, we can enforce that Y is independent of Z1 given Z2 by setting the regression
parameters associated with Z1 to be zero. If all of reduced models were the same, i.e. all studies have the same
covariate information, we have Xk = X, θk = β and gk = f for each k, and the common parameter of interest β∗
can be efficiently estimated by the fixed-effect meta-analysis estimator βˆmeta =
∑K
k=1(
∑K
k=1 S
−1
k )
−1S−1k θˆk, the
variance of which, in turn, can be estimated by Σˆmeta = (
∑K
k=1 S
−1
k )
−1 (van Houwelingen et al. , 2002; Ritz et al. ,
2008; Jackson et al. , 2011).
2.2 A Special Case Involving Linear Regression Model
As readers may find it counter-intuitive to comprehend how it is possible to estimate parameters of the maximal
model as no single study may have ascertained Y and all components of X simultaneously, following we give a linear
model example to help develop insight into the problem. Suppose, one is interested in developing a multiple linear
regression model for Y based on a set of covariates X in the form
Y = α+
K∑
k=1
βkXk + 
where it is further assumed that  ∼ N(0, σ2). Without loss of generality, we will assume that all the variables Y ,
X1, . . . , XK are standardized to have mean zero and variance one. Under this model, the population parameter
β = (β1, . . . , βK)
T can be expressed as β = E(XTX)−1E(XTY ) = R−1E(XTY ), where R is the population
2
correlation matrix of X. Now, suppose we have no data available on Y and mutivariate X on the same sample, but
we have estimates available for parameters (θk, k = 1, ...K) for univariate linear regression models of the form
Y = θkXk + ψk.
From above θk = E(XkY ) and thus θˆ = (θˆ1, . . . , θˆK), provides an estimate of the cross product terms, E(XTY ),
which is required in estimating β. Further, if we have a reference dataset, which has information on multivariate X
but is not required to be linked to Y , it can be use to estimate R, as Rˆ say, and a consistent estimate of β can
be obtained simply as βˆ = Rˆ−1θˆ. Thus, this simple derivation shows that it is possible to estimate parameters
of a multiple regression model using information on parameters of a series of univariate regression models and
a reference dataset. In fact, this observation that information on univariate regression parameters (known as
summary-level statistics) can be utilized to reconstruct estimates of parameters of multivariate regression model has
revolutionized the field of statistical genetics. Recently, a large variety of methods have been developed for the
inference on parameters underlying multivariate regression models utilizing widely available summary-level results
from large GWAS and reference datasets to estimate linkage disequlibrium across genetic markers (Yang et al. ,
2012; Bulik-Sullivan et al. , 2015; Zhu et al. , 2016; Pasaniuc & Price, 2017). In the following, we show a more
general statistical formulation of the problem that allows consideration of non-linear models and use of information
from arbitrary types of reduced models as opposed to simply univariate models.
2.3 Generalized Meta-Analysis
The key idea underlying the proposed generalized meta-analysis is that we convert information on parameters
from reduced models into a set of equations that are informative about the parameters of the maximal model. In
the following, we will make the assumptions (i) the same probability law for (Y,X) holds for all the underlying
populations (ii) f(Y |X;β) is a correctly specified model for the conditional distribution of (Y |X) and (iii) we have
a reference dataset to estimate empirically the joint distribution of all the factors included in X.
Here, we assume all the studies employ a random sampling design and the same probability law for (Y,X)
holds for all the underlying populations. Let sk(y|xAk ; θk) = ∂ log gk(y|xAk ; θk)/∂θk be the score function of the
kth reduced model and denote uk(x;β, θk) =
∫
sk(y|xAk ; θk)f(y|x;β)dy. Assume θˆk is the maximum likelihood
estimator from the kth study and denote θ∗k as the asymptotic limit of θˆk. Irrespective of whether the reduced
models are correct or not, Epr∗{sk(Y |XAk ; θ∗k)} = 0 holds, where pr∗ denotes the true probability law. Assuming
the maximal model is correctly specified, we can write pr∗(Y,XAk) =
∫
X\XAk
f(Y |X;β∗)dF ∗(X). Hence, a general
equation establishing relationship between β∗ and θ∗k is in the form (Chatterjee et al. , 2016)∫
uk(x;β
∗, θ∗k)dF
∗(x) = 0. (1)
As we may not have individual level data from the studies, the above equations cannot be directly evaluated.
Instead, we assume that we have a reference sample of size n, independent of the study samples, on which
measurements on X are available. The reference sample need not to be linked with the outcome Y of interest and
its sample size can be fairly modest compared to the study sample sizes.
With θˆk from the studies and the reference sample {Xi}ni=1, we can set up the estimating equations Un(β, θˆ) =
(1/n)
∑n
i=1 U(Xi;β, θˆ) = 0, where U(x;β, θ) = (u
T
1 (x;β, θ1), . . . , u
T
K(x;β, θK))
T , θˆ = (θˆT1 , . . . , θˆTK)
T and θ =
(θT1 , . . . , θ
T
K)
T . Denote the dimensions of θk and β as dk and p, respectively. Because the number of equations
d =
∑K
k=1 dk can be larger than the number of unknown parameters p, the estimating equations may not be
solved exactly. Following the technique of generalized method of moments , we propose the following generalized
meta-analysis (GENMETA) estimator of β?: βˆ = argminβQCˆ(β) where QCˆ(β) = Un(β, θˆ)
T CˆUn(β, θˆ) and Cˆ
is a positive semi-definite weighting matrix. Following the well established theory of generalized method of
moments (Hansen, 1982; Engle & McFadden, 1994), we derive the asymptotic properties of the GENMETA
estimator. Assume the study summary statistics θˆk are independent across studies; nk1/2(θˆk − θ∗k)→N(0,Σk) in
distribution and limn→∞nk/n = ck > 0 for each k; and the reference sample is independent of the study samples.
Denote Γ = E{∂U(X;β, θ?)/∂β |β=β∗}, ∆ = E{U(X;β∗, θ?)UT (X;β∗, θ?)} and Λ = diag(Λ1, . . . ,ΛK), where
Λk = (1/ck)WkΣkW
T
k and Wk = E{∂uk(X;β∗, θk)/∂θk}|θk=θ∗k for k = 1, . . . ,K.
Theorem 1 (Consistency and Asymptotic Normality of βˆ). Suppose the positive semi-definite weighting matrix
Cˆ→C in probability. Then, under Assumptions (A1)-(A4) in the appendix, βˆ→β∗ in probability. Further, given
β∗ is an interior point and under additional Assumptions (A5)-(A9) in the appendix, n1/2(βˆ − β∗) converges in
distribution to the normal distribution N(0, (ΓTCΓ)−1ΓTC(∆ + Λ)CΓ(ΓTCΓ)−1).
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The optimal C that minimizes the above asymptotic covariance matrix is Copt = (∆+Λ)−1 and the corresponding
optimal asymptotic covariance matrix is {ΓT (∆ + Λ)−1Γ}−1. Because Copt itself depends on unknown underlying
parameters, it requires iterative evaluation. In our applications, we first evaluate an initial GENMETA estimator
with a simple choice of Cˆ such as the identity matrix. We then obtain the iterated GENMETA estimator by
continuing to set Cˆ = Cˆopt based on the latest parameter estimate till convergence. By Theorem 1, βˆ with Copt
approximately follows a Gaussian distribution with mean β∗ and covariance matrix
[ΓT { 1
n
∆ + diag(
1
n1
W1Σ1W
T
1 , . . . ,
1
nK
WKΣKW
T
K)
−1}Γ]−1, (2)
which indicates that the precision of GENMETA depends on the size of the reference sample, n, as well as on those
of the studies, nk. However, as we will see in Section 3, the study sample sizes are the dominating factor controlling
the precision of GENMETA and with fixed nk’s, the precision of GENMETA quickly reaches plateau as a function
of n.
For the implementation of the optimal GENMETA and the variance estimation of any of the GENMETA
estimators, one needs to have valid estimates of Λk, which depend on Σk, the asymptotic covariance matrices
of the estimates of the reduced model parameters. Ideally, the studies should provide robust estimates of the
covariance matrices, such as the sandwich covariance estimators, so that they are valid irrespective of whether
the underlying reduced models are correctly specified or not. In practice, however, while some kind of estimates
of standard errors of the individual parameters are expected to be available from a study, obtaining the desired
robust estimate of the entire covariance matrix could be difficult. When no estimate of Σk is available from
the kth study, one can take the advantage of the reference sample to estimate it by Σˆrefk = Jˆ
−1Vˆ Jˆ−1, where
Jˆ = Pn[EY |X{∇θksk(θk)}]|θk=θˆk , Vˆ = Pn[EY |X{sk(θk)sk(θk)T }]|θk=θˆk , sk(θˆk) = sk(Y | XAk ; θk)|θk=θˆk , θˆk is a
consistent estimator of θ?k, EˆY |X is the expectation with respect to the distribution of Y | X with β? replaced by a
consistent estimator βˆ, and Pn is the empirical measure with respect to the reference sample. Further, assuming
EY |X{∇θksk(θk)}|θk=θ∗k = ∇θkEY |X{sk(θk)}|θk=θ∗k , it follows Λk = (1/ck)E(Y,X){sk(θk)sk(θk)T }|θk=θ∗k , which can
be estimated by Λˆrefk = (1/ck)Pn[EY |X{sk(θk)sk(θk)T }]|θk=θˆk . For example, suppose Y | X and Y | XAk follow
logistic distributions with parameters β? and θk, respectively. Denote X = (1, XT )T and XAk = (1, XTAk)
T . Then,
Λˆrefk =
1
ck
Pn[{(1 + eX
T
Ak
θˆk)−2(1 + e−X
T β)−1 + (1 + e−X
T
Ak
θˆk)−2(1 + eX
T βˆ)−1}XAkXTAk ]. (3)
In section 3, we will study the properties of the GENMETA estimators using either covariance matrices estimated
from studies or the reference sample.
It is insightful to explore the connection between GENMETA and standard meta-analysis when all of the
reduced models are identical to the maximal model, that is, when θ∗k = β
∗, XAk = X and gk = f for each
k. Under this setup, the moment vector evaluated at the true parameters becomes zero for each study, i.e.
uk(X;β
∗, θ∗k) = uk(X;β
∗, β∗) = 0. This simplification implies ∆ = ~0 and thus the optimal weighting matrix is
Copt = Λ
−1 = diag(c1Σ, . . . , cKΣ), where Σ is the inverse of the Fisher’s information matrix of f . Denote by βˆopt
the GENMETA estimator with a consistent estimator of Copt. Then, by arguments similar to those in the proof of
Theorem 1, βˆopt can be expressed as
βˆopt = βˆmeta + op(1/n
1/2),
which implies that βˆopt and βˆmeta are asymptotically equivalent in terms of limiting distributions.
2.4 Generalized Linear Model and Iterated Reweighted Least Square Algorithm
GENMETA computation involves minimization of a quadratic form, QC(β) = UTn (β, θˆ)CUn(β, θˆ), with a known
weighting matrix C. Next, we derive the iterated reweighted least squares algorithm for minimizing the quadratic
form, assuming that the maximal and reduced models belong to the class of generalized linear models [(McCullagh
& Nelder, 1989)]. Specifically, the densities of Y | X and Y | XAk are of the forms exp({1/a(φ)}(yh(xTβ?) −
b{h(xTβ?)}) + c(y;φ)) and exp({1/a(φk)}(yh(xTAkθk)− b{h(xTAkθk}) + c(y;φk)), respectively, where a(·), b(·) and
c(·) are known functions, h(·) = b′−1{g−1(·)}, g is a monotone and differentiable link function, and φ and φk are the
dispersion parameters of the maximal and the kth reduced models, respectively.
First, we assume that the dispersion parameters, φ and φk’s, are known and later we will relax this assumption.
For this case, it follows, for each k,
uk(x;β, θk) = rk(x;β, θk, φk)xAk , (4)
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where rk(x;β, θk, φk) = {1/a(φk)}(g−1(xTβ) − g−1(xTAkθk))h′(xTAkθk). Then, the empirical moment vector is
Un(β, θˆ) = Pn(u1(X;β, θˆ1)
T , . . . , ~uK(X;β, θˆK)
T )T . The Newton-Raphson (NR) method for searching the minimizer
of QC(β) can be written as
β(t+1) = β(t) − (XTrbindW ∗Xrbind)−1XTrbindWXAdiagCXTAdiagr (5)
where Xrbind = 1 ⊗ X and X(n×p) is the reference data matrix; XAdiag = diag(XA1 , . . . , XAK ) and XAk(n×dk)
is the reference data matrix for the kth study; W = diag(W1, . . . ,WK), Wk = diag(wk1, . . . , wkn) and wki =
(1/(a(φk)g
′{g−1(XTi β(t))))h′(XTAk,iθˆk) for k = 1, . . . ,K; i = 1, . . . , n; W ∗ is the sum of WXAdiagCXTAdiagW and
diag(rTXAdiagCXTAdiagL), a diagonalized matrix from a vector; r = (r
T
1 , . . . , r
T
K)
T , rk = (rk1, . . . , rkn)T and rki =
rk( ~Xi;β
(t), θˆk, φk); and ~L = diag(L1, . . . , LK), Lk = diag(lk1, . . . , lkn) and lki = −g′′{g−1(XTi β(t))}/(a(φk)[g′{g−1(XTi β(t))}]3h′(XTAk,iθˆk)).
Equation (5) implies that the Newton-Raphson’s method is an iterated reweighted least squares algorithm.
When φ and φk’s are unknown, we propose to first obtain the GENMETA estimator βˆ of β? as above with φ′ks
replaced by φˆk’s. Next, we consider the estimation of φ?, the true value of φ. For the kth reduced model, we have
an additional score function with respect to φk, from which, similar to equation (4), we can obtain
uk(X;β, φ, θk, φk) = − a
′(φk)
a2(φk)
(g−1(XTβ)h(XTAkθk)− b{h(XTAkθk)}) + qk(X;β, φ, φk),
where qk = EY |X{c′(Y ;φk)} and c′(Y ;φk) is the derivative of c(Y ;φk) with respect to φk. Then, the empirical
moment vector for φ is Un(φ) = Pn(u1(X; βˆ, φ, θˆ1, φˆ1)T , . . . , uK(X; βˆ, φ, θˆK , φˆK)T )T . To estimate φ?, we need to
compute the minimizer of Un(φ)TCUn(φ), where C is a known weighting matrix. The Newton-Raphson steps can
be written as
φ(t+1) = φ(t) − J−1n (φ(t))Dn(φ(t)), (6)
where Jn(φ) = UTn (φ)Cd2qn(φ)/dφ2 + (dqn(φ)/dφ)TCdqn(φ)/dφ, Dn(φ) = UTn (φ(t))Cdqn(φ)/dφ and qn(φ) =
Pn(q1(X; βˆ, φ, φˆ1), . . . , qK(X; βˆ, φ, φˆK))
T . In brief, when φ and φk, k = 1, . . . ,K, are unknown, we first choose
initial estimates β(0) and φ(0). Then, we get the GENMETA estimator βˆ by using equation (5) until a stopping rule
is reached. Subsequently, φ(0), βˆ and the study estimates are plugged in equation (21) and the process is repeated
until a stopping rule is reached to get the GENMETA estimator of φ∗. In each NR step, the weighting matrix C is
estimated by the estimates from the previous step.
2.5 Diagnostic Test for Model Violation
GENMETA relies on several modeling assumptions, including homogeneity of the underlying populations with
respect to the distribution of covariates and regression parameters, and correct specification of the maximal model.
In the absence of individual level data from the different studies, these assumptions could not be tested in the
usual manner using traditional diagnostic tests. However, even with summary-level data, some diagnostic testing
is possible. In particular, from an intuitive perspective, departure of the GENMETA estimating equations, when
evaluated at estimated parameter values, from their expected null value will be indicative of disagreement between
the model and the observed data, i.e. the estimates of the parameters from the reduced models from different
studies. For example, if the regression parameters underlying the maximal model are highly heterogeneous across
studies, then the assumption of a common β in GENMETA will not be able to explain the heterogeneity that is
expected to be present in overlapping reduced model parameters across the studies. Specifically, we propose to use
the score test based on the statistic, TGENMETA = nQCˆopt(βˆ), where βˆ is the GENMETA estimate. When all the
underlying assumptions are correct, from the standard generalized method of moments theory, TGENMETA converges
in distribution to a χ2 distribution with d − p degrees of freedom, where d is the total number of GENMETA
equations and p is the total number of underlying parameters that are being estimated. The test is only applicable
when d > p, which arises when different studies have overlapping covariates.
3 Simulations
We study the performance of the GENMETA estimators through simulation studies in both idealized and non-
idealized settings. In all simulations, we assume that the relationship between a binary outcome variable Y and
three covariates (X1, X2, X3) can be described by a logistic regression model of the form
Y | (X1, X2, X3) ∼ Bernoulli([1 + exp{−(β∗0 + β∗1X1 + β∗2X2 + β∗3X3)}]−1) (7)
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Table 1: Results on the GENMETA estimators
n = 50 β∗i Bias SD (ESD1, ESD2) RMSE CR AL
β∗1 .010 .161 (.161, .162) .161 .968, .964 .642, .636
GENMETA.0 β∗2 .005 .110 (.111, .108) .110 .958, .960 .434, .423
β∗3 -.001 .138 (.143, .142) .138 .963, .964 .559, .556
β∗1 .005 .117 (.116, .110) .117 .976, .966 .455, .433
GENMETA.1 β∗2 -.003 .101 (.105, .099) .101 .964, .955 .411, .386
β∗3 .001 .099 (.102, .097) .099 .973, .961 .402, .381
β∗1 .007 .115 (.116, .111) .115 .971, .964 .455, .435
GENMETA.2 β∗2 -.003 .102 (.105, .099) .102 .960, .959 .413, .388
β∗3 .003 .098 (.103, .098) .098 .957, .957 .403, .383
Biases, standard deviation (SD), estimated standard deviation (ESD), square roots of mean
square errors (RMSE), coverage rates (CR) and average lengths (AL) of 95% confidence
intervals for GENMETA.0 (the initial GENMETA estimator with identity weighting ma-
trix), GENMETA.1 and GENMETA.2 (the iterated GENMETA estimators without and
with using the study covariance estimators) in the logistic regression setting. Standard de-
viations were estimated either using the reference sample (ESD1) or using the covariance
estimates of reduced model parameters from the studies (ESD2). Estimated standard devia-
tions are reported by taking averages over simulated datasets. Both estimated SE’s are used
to construct 95% confidence intervals and their CR’s and AL’s are reported.
where (X1, X2, X3) follows a multivariate normal distribution with mean µ = (µ1, µ2, µ3), variance σ2 = (σ21 , σ22 , σ23)
and underlying correlations ρ = (ρ12, ρ13, ρ23). We chose β∗1 = β∗2 = β∗3 = log 1.3 to reflect a moderate degree of
association of the outcome with each covariate after adjusting for the others. We assume existence of three separate
studies, where each study fits a reduced logistic model for the outcome Y on two of the covariates in the form
Y | (Xi, Xj) ∼ Bernoulli((1 + exp{−(θ∗0,ij + θ∗i,ijXi + θ∗j,ijXj , )})−1), (8)
with X1 and X2 included in Study-I, X2 and X3 in Study-II and X1 and X3 in Study-III. Here, as data for each study
are generated using the maximal model, the reduced models are by definition incompatible due to non-collapsibility
of the logistic model. We fix the sample size of the studies at n1 = 300, n2 = 500 and n3 = 1000 and vary the
sample size of the reference dataset.
3.1 Homogeneous Population
We assume that the studies are conducted in the same underlying population from which the reference sample is
drawn. Under this setting, there exists a common mean vector µb = (0, 0, 0), common variance vector σ2b = (1, 1, 1)
and common correlation vector ρb = 0.3, 0.6, 0.1), that describes the joint distribution of the three covariates
across all the underlying populations. In the first set of simulation, we assume a fixed sample size n = 50 for the
reference dataset. In all settings, we simulate data (Y,X1, X2, X3) for the underlying studies based on the data
generating models as described above and fit the respective reduced models to obtain estimates of the reduced
model parameters. For each set of simulated data, we obtain estimates of covariance matrices of the reduced model
parameters using robust sandwich estimators based on either the study datasets themselves, or the reference dataset
(see (3)). We consider three GENMETA estimators: GENMETA.0, which is the initial GENMETA estimator with
identity weighting matrix and GENMETA.1 and GENMETA.2, that use covariance estimates from the reference
dataset and the studies, respectively.
From the results shown in Table ??, we observe that all three GENMETA estimators are nearly unbiased. The
standard error estimates, irrespective of whether Σk, k = 1, 2, 3 were estimated using the study data sets or the
reference sample, accurately reflected the true standard errors of the GENMETA parameter estimates across different
simulations. As a result, the 95% confidence intervals maintained the coverage probability at the nominal level.
Among the three GENMETA estimators considered, clearly GENMETA.0, which use the non-optimal choice of
C = I, is less efficient than GENMETA.1 and GENMETA.2, which, between themselves, had comparable efficiency.
In the same setting as above, when we vary n from 10 up to the maximum of 1000 (Figure 1), we observe that
the precision of the GENMETA estimates do not increase with n once it reaches a threshold around 100, which is
one third of the minimum of the study sample sizes(n1 = 300). These thresholds were even smaller for estimation of
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Figure 1: Square roots of mean square errors (RMSE) of GENMETA estimators for β∗1 , β∗2 and β∗3 with fixed study
sample sizes n1 = 300, n2 = 500 and n3 = 1000 and varying reference sample size n from 10, 30, 50, 70, 100, 200 to
1000. The circle and solid line are for the RMSE’s of GENMETA.0; the triangle and dashed line are for those of
GENMETA.1; the plus and dotted line are for those of GENMETA.2.
coefficients associated with X2, which had weak to moderate correlation with the other covariates in the model. The
fact that the reference dataset can be substantially smaller than the study datasets without having much impact on
the precision of the GENMETA estimator is encouraging given that accessing reference dataset of large sample size
may be difficult in practice.
Finally, we conduct additional simulation studies to obtain more insight into results from the real data analysis
(Section 4). Here, the settings are similar to before except we assume there are only two studies: study-I fits the
maximal logistic regression model involving all the three covariates and study-II involves only two covariates, namely
X1 and X2. We assume ρI = ρII = ρb. In our estimation, we further considered an added complexity to account for
study specific intercept terms for the maximal logistic regression model
Y | (X1, X2, X3, study) ∼ Bernoulli([1 + exp{−(β∗0,study + β∗1X1 + β∗2X2 + β∗3X3)}]−1)
so that the prevalence of the outcome, pr(Y = 1), could be different across the two studies. In this set-
ting, the maximal set of parameters that are to be estimated through GENMETA can be defined as β∗ =
(β0,study-I, β0,study-II, β1, β2, β3). We simulated data using values of intercept parameters that are identical across
the two models, but for estimation we allowed the intercept parameters to be different. For the sake of comparison,
we also fitted a reduced model for study-I and conducted a standard multivariate meta-analysis of the underlying
common parameters (θ1 and θ2) across the two studies. We assume the sample sizes for the two studies to be
n1 = 500 and n2 = 5000, and that for the reference dataset to be n = 300.
From the results reported in Table 2, we observe that in this simulation setting the reduced models produce
biased estimate for β∗1 , but not for β∗2 . The result is intuitive given that the omitted covariate X3 is primarily
correlated with X1. As a result, standard meta-analysis was nearly unbiased for β∗2 , but not for β∗1 . Parameter
estimates from the maximal model from study-I are unbiased for all parameters, but have much larger standard
error compared to meta-analysis for estimation of β∗2 . The GENMETA estimator produced unbiased estimates
for all parameters and at the same time has comparable efficiency as standard meta-analysis for estimation of β∗2 .
These results highlight the desirable feature of the GENMETA estimator that it can effectively combine information
across studies to minimize bias due to omitted covariates and yet utilize all the information available across the
partially informative studies.
3.2 Heterogeneous Population
In this section, we consider simulation studies where the underlying assumption of the homogeneity of covariate
distribution across populations may be violated in multiple different ways. As a bench mark for comparison, we will
describe setting (I) as the same setting as the the one we simulate under homogeneous population. In the setting
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Table 2: A Simulation for Understanding Real Data Analysis
Study I Study II Meta GENMETA
Maximal Reduced Reduced Reduced Reduced Maximal
β∗i PE (SD) PE (SD) PE (SD) PE (SD) PE (SD) PE (SD)
β∗1 .270 (.149) .429 (.116) .424 (.037) .424 (.035) .425 (.035) .268 (.088)
β∗2 .263 (.111) .243 (.112) .236 (.035) .236 (.034) .237 (.034) .263 (.039)
β∗3 .258 (.136) NA NA NA NA .255 (.135)
Point estimates (PE) and standard deviations (SD) from logistic regression with reduced and
maximal models, meta-analysis and GENMETA estimation with β∗1 = β∗2 = β∗3 = log(1.3) ≈ .262.
NA means there is no corresponding estimator.
(II), we allow the means or/and variances to vary across the populations underlying the studies and reference sample,
keeping the correlations to remain constant. Specifically, we assume the mean-vector for the three covariates can
take one of three possible values: µh = (1, 1, 1), µm = (0.5, 0.5, 0.5) and µb = (0, 0, 0). Similarly, the variance-vector
is also allowed to vary across three possible set of values: σ2h = (2, 2, 2), σ
2
l = (0.5, 0.5, 0.5), σ
2
b = (1, 1, 1). In the
setting (III), we then allow the correlations among the covariates to vary across populations. Here we also allow
three possible set of correlation vector ρ as ρl = (0.2, 0.4, 0.0) , ρh = (0.4, 0.8, 0.2) and ρb = 0.3, 0.6, 0.1). Finally, we
consider simulation setting (IV), where we allow for potential different inclusion criteria across studies leading to
possible violations of the assumption of homogeneity of the covariate distribution. Specifically, we first simulate an
underlying study base using the setup described in simulation setup (I), and then for study-I we only keep individuals
with X1 > −0.5 and X2 < 0.5, and in study-II we keep individuals with X1 > 0. Finally, we consider an alternative
simulation scenario where we assume the covariates are log-normally distributed by defining X = exp(W ), where W
is generated from multivariate normal distribution following the same settings as I-IV described above
When covariates were normally distributed, we observe that (see Table 3) the proposed method is not very
sensitive to underlying assumption of homogeneity of covariate distribution. In the setting (II), where the mean
or/and variances of the covariates are varied across the population, but correlations are kept fixed, there is virtually
no bias. In setting (III), where correlations are varied, we observe more noticeable, but still small, biases in parameter
estimates. In setting (IV), when the inclusion criteria are varied across studies, there is also very minimal bias.
When covariates are log-normally distributed, however, we observe that (see Table 1 in Supplementary Material)
the method could be more sensitive to the violation of the underlying homogeneity assumption. In particular, when
the inclusion criteria varied across studies (setting IV), large bias in point estimate and low coverage probability are
observed for estimation of coefficient associated with X2, the covariate which is used to define fairly non-overlapping
inclusion criterion across two studies. Notably, even in this scenario, minimal bias is observed for estimation of the
other covariates in the model.
3.3 Power Evaluation of the Diagnostic Test (TGENMETA)
We assess the power of the proposed test statistic, TGENMETA in the presence of heterogeneity in the regression
parameters (β) across the studies. In the context of standard multivariate meta-analysis, where it is assumed that
all the studies ascertain the same set of covariates, test for heterogeneity is performed using standard multivariate
Cochran’s test-statistic in the form
Q =
K∑
k=1
(βˆk − βˆmeta)TS−1k (βˆk − βˆmeta)
where βˆmeta is the usual multivariate meta-analysis estimate and Sk is the standard error of βˆk for k = 1, . . . ,K.
We will utilize Q as a benchmark to evaluate the power of TGENMETA.
In all simulations, as before, we assume the existence of three separate studies and relationship between a
binary outcome variable Y and three covariates (X1, X2, X3) in each study follows the same logistic regression
model of the form (7). However, instead of assuming a fixed set of β across all studies, we simulate different
values of β from a normal distribution with mean (β∗0 , β∗1 , β∗2 , β∗3) = (log 1.3, log 1.3, log 1.3) and variance σ2I, where
the parameter σ2 > 0 is varied to control the degree of heterogeneity across studies. As before, we assume that
(X1, X2, X3) follows a multivariate normal distribution with mean zero, unit variances and underlying correlations
ρ = ρ12 = 0.3, ρ13 = 0.6, ρ23 = 0.1) across all the three studies. We simulate data for the different studies from the
above random-effects logistic regression model and then fit reduced models of the form (8) to the three different
8
Table 3: Robustness of GENMETA Estimation (Normally Distributed Covariates)
Setting Study-I Study-II Study-III Reference β∗i Bias SD (ESD) RMSE CR AL
µb µb µb µb β
∗
1 .001 .111 (.112) .111 .947 .437
I σ2b σ
2
b σ
2
b σ
2
b β
∗
2 -.002 .098 (.099) .098 .956 .389
ρb ρb ρb ρb β
∗
3 .005 .096 (.098) .096 .954 .382
µb µh µm µb β
∗
1 .010 .103 (.104) .103 .952 .405
σ2b σ
2
b σ
2
b σ
2
b β
∗
2 -.006 .083 (.083) .083 .954 .324
ρb ρb ρb ρb β
∗
3 .005 .085 (.088) .085 .956 .343
µb µb µb µb β
∗
1 .003 .139 (.136) .139 .939 .529
II σ2b σ
2
h σ
2
l σ
2
b β
∗
2 -.003 .084 (.086) .084 .956 .335
ρb ρb ρb ρb β
∗
3 .003 .112 (.111) .112 .949 .431
µb µh µm µb β
∗
1 .013 .124 (.126) .125 .946 .493
σ2b σ
2
h σ
2
l σ
2
b β
∗
2 -.006 .073 (.075) .073 .958 .291
ρb ρb ρb ρb β
∗
3 .005 .097 (.100) .097 .949 .391
µb µb µb µb β
∗
1 -.092 .142 (.151) .169 .958 .579
σ2b σ
2
b σ
2
b σ
2
b β
∗
2 .019 .105 (.109) .107 .963 .423
ρb ρb ρb ρh β
∗
3 .053 .120 (.129) .131 .971 .495
µb µb µb µb β
∗
1 .035 .099 (.099) .106 .917 .385
σ2b σ
2
b σ
2
b σ
2
b β
∗
2 .002 .096 (.096) .096 .954 .377
ρb ρb ρb ρl β
∗
3 .012 .087 (.087) .088 .944 .343
µb µb µb µb β
∗
1 .060 .113 (.113) .128 .916 .443
III σ2b σ
2
b σ
2
b σ
2
b β
∗
2 -.001 .096 (.097) .096 .955 .379
ρl ρb ρh ρl β
∗
3 -.006 .103 (.102) .104 .944 .398
µb µb µb µb β
∗
1 .039 .130 (.132) .135 .939 .515
σ2b σ
2
b σ
2
b σ
2
b β
∗
2 -.006 .097 (.100) .097 .958 .392
ρl ρb ρh ρb β
∗
3 -.027 .116 (.118) .119 .944 .461
µb µb µb µb β
∗
1 -.036 .165 (.173) .169 .957 .671
σ2b σ
2
b σ
2
b σ
2
b β
∗
2 .013 .103 (.109) .104 .962 .424
ρl ρb ρh ρh β
∗
3 .003 .143 (.153) .143 .959 .591
µb µb β
∗
1 .014 .123 (.127) .124 .961 .494
IV X1 > −0.5, X2 > 0 σ2b σ2b β∗2 -.008 .105 (.109) .105 .965 .428
X2 < 0.5 ρb ρb β
∗
3 -.001 .094 (.093) .093 .958 .366
Biases, standard deviation (SD), estimated standard deviation (ESD), square roots of mean square errors (RMSE),
coverage rates (CR), and average lengths (AL) of 95% confidence intervals of the GENMETA estimates using the study
covariance estimators in the setting of logistic regression. In setting (I), data are simulated in ideal setting there the
covariate distribution, characterized by mean, sd and correlation of normal variates, are assumed to same across all
populations. In setting (II)-(IV), the assumption is violated by creating variations in mean/sd, correlations and selection
criterion across the studies and reference sample. with different study and reference sample. The vector of covariate
means, variances and correlations are denoted by denoted by µ∗ = (µ1, µ2, µ3), σ2∗ = (σ21 , σ22 , σ23) and ρ∗ = (ρ12, ρ23, ρ13)
for ∗ ∈ {b, l,m, h}, where µb = (0, 0, 0), µm = (0.5, 0.5, 0.5), µh = (1, 1, 1); σ2b = (1, 1, 1), σ2l = (0.5, 0.5, 0.5), σ2h =
(2, 2, 2) and ρb = (0.3, 0.6, 0.1), ρh = (0.4, 0.8, 0.2), ρl = (0.2, 0.4, 0). Estimated standard deviation are obtained by the
asymptotic formula (2) and used to construct 95% confidence interval.
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Figure 2: Power curves of simple multivariate meta-analysis test statistic (Q) and TGENMETA for simulated datasets.
The long-dashed line is for the simple meta-analysis estimator. The solid and dotted lines are for GENMETA
estimators with reference data sample sizes 100 and 500, respectively. Level of the test (α) is set to 0.05.
studies. In particular, we assume X1 and X2 included in Study-I, X2 and X3 in Study-II and X1 and X3 in Study-III.
We fix the sample size of the studies at n1 = 3000, n2 = 5000 and n3 = 10000 and vary sample size of the reference
dataset. The level of the test is set to 5%. For the purpose of comparison, we also fit the maximal model to each
study involving all three covariates and apply the standard Q-statistics for testing heterogeneity.
Comparison of power of TGENMETA and Q statistics shows that, as expected, the power for both tests increases
as a function of degree of heterogeneity, σ2 (Figure 2). Clearly, TGENMETA suffers some loss of power as it handles
missing covariates, but it retains substantial power, even with small reference dataset (n = 100), to remain practically
useful.
4 Real Data Analysis
In this section, we illustrate an application of the proposed methodology to develop a model for predicting risk of
breast cancer based on combination of different risk factors using data from multiple studies. The first study, the
Breast Prostate Colorectal Cancer Cohort study (BPC3), includes a total of 7448 cases and 8812 controls, drawn
from eight different underlying cohorts. Details of the study, including its recent application for the development
of breast cancer risk prediction model, can be found elsewhere (Mass et al. , 2016). In the current analysis, we
focus on the analysis of breast cancer risk associated with a selected set of factors, including family history, age
at menarche, age at first birth and weight. The second study involves a dataset involving 1217 cases and 1616
controls from the Breast Cancer Detection and Demonstration Project (BCDDP). The study has been previously
used to develop an updated version of the widely popular Breast Cancer Risk Assessment tool (Chen et al. , 2006)
to incorporate mammographic density, the areal proportion of breast tissue that is radiographically dense, known to
be a strong risk factor for breast cancer. The dataset from the BCDDP study included mammographic density and
number of previous breast biopsy, in addition to all the factors considered in the BPC3 data analysis. Let X denote
the common set of covariates that are measured across both the studies and Z be the factors that are available
only in BCDDP. The goal is to estimate parameters associated with an underlying logistic regression model that
includes all of the different factors. While the BPC3 study is large in size and represents multiple populations, it
has information on more limited number of risk factors. The BCDDP study, on the other hand, has information on
extended set of risk factors, but is much smaller in size. A combined analysis of these two studies can potentially
lead to more generalizable and precise estimate of risk parameters.
Throughout the analysis, we used a sample of 137 cases and 163 controls from the BCDDP study as the reference
sample based on which the distribution of covariates are estimated. To maintain independence of the reference
and study samples, we exclude the reference sample from the primary analysis of the BCDDP study that involved
estimation of the log-odds-ratio parameters. Further, both the studies involve case-control sampling with similar
case-control proportions. In general, if non-random sampling is used for selection of subjects in any of the studies,
then the covariate distribution underlying the GENMETA estimating equation needs to be adjusted to account
for the study design. In this application, because we had access to the the BCDDP study, we could adjust for the
design effect by simply selecting a reference sample that includes cases and controls in similar ratio as the main
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studies. In general, however, the effect of non-random sampling design for the main studies may need to adjusted
through careful weighting of subjects in the reference sample.
For each of the eight cohorts within the BPC3 study and for the BCCDP study, we first fit a reduced logistic
regression model including X. All models included age as an additional cofactor and included study specific intercept
parameters and age effects. Specifically, we consider underlying models in the form
(Y | X,Age, study = k) ∼ Bernoulli((1 + exp{−(θ0k + θAkAge+ θTXX)})−1). (9)
We applied the diagnostic test for model violation to these datasets. We found the value of the test-statistic
(TˆGENMETA) to be 59.01 and the corresponding p-value to be 0.366 under a χ2(56) distribution. Thus, it appears
that the underlying model assumptions are unlikely to be grossly violated in this application.
First, to illustrate how the proposed GENMETA estimator compares to standard meta-analysis method, we
consider estimating the common underlying parameters of interest θX using these two alternative methods. We
fitted model (9) separately for each study and obtained estimates of the parameters and covariance matrices. Then,
for the underlying common parameter of interests θX , we conducted a standard multivariate meta-analysis using
the corresponding subset of parameters estimates and covariance matrices. Alternatively, using the parameters
estimates and variance-covariance matrices from the individual studies, and using the set aside BCDDP sample
as the reference dataset to estimate the joint distribution of X and age, we estimated all of the parameters of
model (9) using the GENMETA procedure. From the results reported in Table 4, we observe that in this setting,
the meta-analysis and GENMETA estimators produce similar estimates as well as their standard errors across
all the different risk-factors of interest. In one of the results stated earlier, we have seen theoretically that in an
idealized setting where all the models and underlying populations are identical, the two estimators are asymptotically
equivalent. It’s encouraging to observe the close correspondence between the estimators in the data analysis, which
includes a diverse set of studies that are likely to have significant heterogeneity across the underlying populations.
In particular, for a number of the risk-factors (e.g family history), coefficient estimates were noticeably different
across the two studies. When significant heterogeneity existed, the meta-analyzed estimates were pooled closer to
those from the BPC3 study due to its large sample size.
Next, we turn our attention to the analysis of data from the BCDDP study using a maximal model that includes
X and the additional covariates, mammographic density and number of previous breast biopsy. Comparison of the
parameter estimates associated with X across the maximal and reduced model within the BCDDP study indicates
major differences in the estimates of the coefficients associated with weight. In the maximal model, higher weight is
found to be be much more strongly associated with increased risk of breast cancer. The unmasking of the effect
of weight in the maximal model is intuitive given that body weight and mammographic density is known to have
strong negative correlation. Although not as dramatic, there are some differences in effects of age at menarchy and
age at first birth between the maximal and reduced models, also possibly because of modest correlation of these
factors with mammographic density and number of previous breast biopsy. The effect of family history, however, is
almost identical across the two models.
Finally, we used the GENMETA method to combine estimates of the parameters of the maximal model from
the BCDDP study and those from the reduced models from the eight BPC3 cohorts. We assumed an underlying
maximal model of interest across the 9 studies in the form
(Y | X,Z,Age, study=k) ∼ Bernoulli([1 + exp{−(θ0k + θAkAge+ βTXX + βTZZ)}]−1).
We observe that GENMETA produces estimates of effect of family history and associated standard error very
similar to those observed based on the standard meta-analysis of the reduced models across the nine cohorts. The
estimate is pooled heavily towards the BPC3 study due to its large sample size. In contrast, the GENMETA
estimates for weight are very similar to those observed from the maximal model only within the BCDDP study. These
results are consistent with simulation studies, where GENMETA behaves similar to reduced model meta-analysis
when omitted covariates do not cause notable bias. In contrast, when omitted covariates cause important bias, the
GENMETA estimator is pooled towards estimates from maximal or more complete models that may be available
from a restricted set of studies. The behavior of GENMETA for the two other covariates, age at menarchy and age at
first birth, were in between, which is also intuitive given that we had observed their coefficients changed notably, but
less dramatically, in the maximal model compared to the reduced model within the BCDDP study. The GENMETA
parameter estimates and standard errors for the additional variables mammographic density and number of previous
breast biopsy, were similar to those observed for the maximal model in the BCDDP, the only study which had
information on these two factors. Thus, overall the data analysis illustrates that the GENMETA estimator behaves
in a similar manner as meta-analysis for combining information across multiple possibly heterogeneous studies, but
it has the added flexibility to effectively combine information from disparate models.
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5 Discussion
The proposed method can be viewed as a natural extension of the traditional fixed effect meta-analysis method that
is widely used in practice. Both simulation studies and data analysis demonstrate that the method not only provides
theoretically valid and efficient inference in idealized conditions, but also can perform robustly in non-idealized
settings. A critical element of the proposed method is the access to a reference dataset. While the ideal choice
of the reference dataset will vary by applications, publicly available survey data, which collect information on a
wide variety of factors, can be useful broadly. In fact, in large scale genetic association studies, use of reference
samples, such as the 1000 Genome study, are commonly used for estimation correlation parameters across genetic
markers in the genome (Consortium, 2012, 2015; Lee et al. , 2013). For epidemiologic studies, good resources
for reference dataset for the US population include the National Health Interview Survey (Adams et al. , 1999;
Botman & Moriarity, 2000; Bloom et al. , 2010) and the National Health and Nutrional Examination Survey (Fang
& Alderman, 2000; He et al. , 2001; de Ferranti et al. , 2006; Idler & Angel, 2011; LaKind et al. , 2012), which
routinely collect data on a wide variety of health and lifestyle related factors. If multiple studies coordinate through
consortium effort, which is increasingly common in biomedical applications, then studies which have most complete
information, at least on some sub-samples, can provide reference sample.
When information on all covariates are not available in a single reference sample, one may have to consider
simulation for generating such data by combining information from multiple studies under some modeling assumptions.
As the access to large reference dataset that is ideally representative of the underlying study populations can be
difficult, we found two aspects of GENMETA to be appealing. First, the sample size for the reference dataset can be
small relative to the study datasets and yet GENMETA can have reasonable efficiency. In fact, increasing the sample
size for the reference dataset beyond certain threshold does not have an impact on the efficiency of GENMETA.
Second, although technically the method requires all the populations underlying the studies and the reference
dataset to be the same, in practice, the method can be robust to a reasonable degree of heterogeneity in distribution
of covariates. However, it is possible to have a large bias when estimating coefficients associated with covariates that
have been used to define widely varying inclusion criteria. When different studies follow very different designs it is
best to obtain study-specific reference samples for estimating the underlying moment equations. Alternatively, it
may be possible to modify a large reference sample by using study-specific sampling weights/inclusion criteria when
estimating the moment equations. Dealing with study-specific covariates, such as centers within a study, can also
pose challenges as information on such variables are not expected to be available from a common reference sample.
We have illustrated in our data example that it is possible to deal with such variables by imposing additional
independence assumptions from other factors. In general, such complications need to be dealt in a case-by-case basis
and some study specific reference samples may be needed to avoid making strong assumptions. Further research is
merited to explore these and other practical challenges in implementation of the proposed method.
In general, we believe caution is needed for interpretations and applications of models that may be developed
by combining information from disparate models across multiple studies. A model developed from a single study
with complete information, although may be inefficient and may lack generalizability, is more likely to be internally
consistent and thus can provide valid etiologic inference even if it is not representative of the general population.
On the other hand, etiologic interpretation of parameters can be difficult when the underlying model is developed
using information across multiple studies that are potentially heterogeneous. For the development of predictive
models, however, where the focus is not so much parameter interpretation, development of rich models by combining
information across multiple studies and then validating such models in independent studies can be an appealing
strategy. These and other practical issues related to model development using multiple data sources have been also
discussed in several recent articles (Wang et al. , 2015; Han & Lawless, 2017; Cheng et al. , 2018; Estes et al. , 2018;
Cheng et al. , 2018).
In this article, we used generalized method of moments as the underlying inferential framework. Alternatively,
inference could be also performed using empirical likelihood theory (Qin & Lawless, 1994; Qin, 2000; Chatterjee
et al. , 2016) exploiting the same set of moment equations as we propose. While in small sample, empirical likelihood
estimators may perform better, implementation can be substantially more complex. Recently, a simulation based
method has been also described for combining information on model parameters across disparate studies (Rahmandad
et al. , 2017). Computationally, the proposed method may also enjoy substantial advantages in dealing with complex
models, such as those in high-dimensional settings, where repeated model fitting on simulated data is extensive.
Further research is merited in multiple directions to increase the practical utility of GENMETA. It is possible
that in some applications we may have information only on subsets of parameters underlying the fitted reduced
models. It’s an open question how such partial information can be used to set up the underlying moment equations
in the GENMETA procedure. Ideally, to increase robustness of inference, the GENMETA procedure should use
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study specific reference sample for setting up the moment equations. For this purpose, it may be useful to develop
strategies to combine information on a common reference sample with complete covariate information and data
from individual studies that have partial covariate information.
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Table 4: Real Data Analysis Results with Meta-Analysis and GENMETA Method
BCDDP BPC3 Meta GENMETA
Maximal Reduced CPS2 EPIC MCCS MEC NHS PLCO WHI WHS Reduced Reduced Maximal
Model Model Cohort Cohort Cohort Cohort Cohort Cohort Cohort Cohort Model Model Model
Risk Factors PE(SE) PE(SE) PE(SE) PE(SE) PE(SE) PE(SE) PE(SE) PE(SE) PE(SE) PE(SE) PE(SE) PE(SE) PE(SE)
FH1 .80(.14) .80(.14) .47(.13) .29(.15) .56(.19) .41(.28) .48(.08) .39(.13) .30(.06) .28(.19) .40(.04) .42(.04) .37(.08)
AMEN1 .11(.10) .07(.10) -.03(.14) .02(.09) -.19(.17) -.09(.24) .06(.09) -.05(.12) .13(.08) .03(.17) .04(.04) .03(.04) .04(.06)
AMEN2 .55(.15) .45(.15) -.09(.17) .04(.12) -.44(.23) .35(.35) .19(.10) .03(.15) .19(.09) .14(.19) .13(.05) .13(.05) .32(.08)
AFB1 .06(.14) .18(.15) .28(.17) .12(.14) -.08(.25) .06(.17) .39(.20) .16(.14) .19(.09) .92(.23) .21(.05) .20(.05) .05(.09)
AFB2 .29(.20) .46(.20) .73(.24) .24(.17) .35(.30) .05(.26) .36(.22) .52(.22) .44(.13) .96(.28) .38(.06) .38(.07) .21(.12)
WT1 .29(.11) .09(.11) .09(.14) -.01(.09) .22(.18) .09(.17) .21(.08) .09(.13) -.03(.08) -.01(.14) .08(.04) .08(.04) .31(.07)
WT2 .52(.13) .10(.13) .16(.14) .24(.11) .45(.19) -.08(.18) .10(.08) .09(.13) .18(.08) -.16(.15) .14(.04) .14(.04) .63(.09)
NBIOPS .13(.09) NA NA NA NA NA NA NA NA NA NA NA .13(.10)
MD .46(.05) NA NA NA NA NA NA NA NA NA NA NA .43(.06)
Combined analysis of BCDDP and BPC3 study to develop a multivariate logistic regression model for breast cancer risk. For each cohort within BPC3 and for BCDDP, standard
logistic regression model is applied for fitting reduced models including FH (family history), AMEN (age at menarche), AFB (age at first live birth) and WT (weight). Parameter
estimates of the reduced models across studies are then combined using standard meta-analysis (meta) or GENMETA. For the BCDDP study, a maximal logistic model is fitted
including additional covariates mammographic density (MD) and number of previous biopsy (NBIOPS). These estimates are then combined with with estimates of reduced model
parameters from BPC3 studies to obtain GENMETA estimates of the maximal model. Point estimates (PE) and standard errors (SE) are shown for each analysis. NA means
there is no corresponding estimator. The variables analyzed include: FH: binary indicator of family history; AMEN1 and AMEN2: dummy variables associated with age-at-
menarche categories ≥ 14, 12–13 and ≤ 11; AFB1 and AFB2: dummy variables associated with age-at-first-live-birth categories ≤ 20, 21–29 and ≥ 30; WT1 and WT2: dummy
variables associated with weight categories ≤ 62.6, 62.6–73.1 and ≥ 73.1 in kilograms; NBIOPS: the number of biopsies coded as a continuous variable and MD: the standardized
mammographic density coded as a continuous variable. BPC3 contains eight cohorts with abbreviated names CPS2, EPIC, MCCS, MEC, NHS, PLCO, WHI and WHS.
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Appendix
Assumptions of Theorem 1
Assumptions (A1)-(A4) are for consistency and the additional assumptions (A5)-(A9) are for asymptotic normality.
(A1): C is positive semi-definite and CE{U(X;β, θ∗)} = 0 if and only if β = β∗.
(A2): β∗ ∈ Dβ , which is compact.
(A3): uk(X;β, θk) is continuous for each (β, θk) ∈ Dβ × N (θ∗k) with probability one, where N (θ∗k) is a
neighborhood of θ∗k for k = 1, . . . ,K.
(A4): E{sup(β,θk)∈Dβ×N (θ∗k) ||uk(X;β, θk)||} <∞ for k = 1, . . . ,K.
(A5): ∂uk(X;β, θk)/∂β is continuous at each (β, θk) ∈ N (β∗) × N (θ∗k) with probability 1, where N(β∗) is a
neighborhood of β∗.
(A6): E{sup(β,θk)∈N (β∗)×N (θ∗k) ||∂uk(X,β, θk)/∂β||} <∞.
(A7): ∂uk(X;β∗, θk)/∂θk is continuous at each θk ∈ N (θ∗k) with probability one.
(A8): E{supθk∈N (θ∗k) ||∂uk(X,β∗, θk)||/∂θk} <∞.
(A9): ∆(β∗, θ∗) exists and is finite and Γ(β∗, θ∗) is of full rank.
More on the Global Identification Assumption (A1)
Sometimes it’s difficult to practically check the global identification condition. This motivates us to investigate
conditions for local identifiability, or equivalently, the invertibility of the matrix of second derivatives at the true
parameter, i.e., ∂2Q(β)/∂β2 |β=β∗= [E{∂U(X;β)/∂β}TCE{∂U(X;β)/∂β}] |β=β∗ (Rothenberg, 1971; Engle and
McFadden, 1994), assuming C is a positive definite matrix. The condition can be stated in terms of the equivalent
sample version of the matrix, given by, XTrbindWXAdiagCX
T
Adiag
WXrbind. As C is a positive definite matrix, the
entire local identifiability condition for the sample version then boils down to XTAdiagWXrbind being a full column
rank matrix. A sufficient condition for this is XAdiag contains information on all the covariates of the maximal
model. In other words, the individual covariates in the maximal model have to be part of at least one of the reduced
models.
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A Supplementary
A.1 Asymptotic Equivalence of GENMETA Estimator and Simple Meta-Analysis
Estimator When All the Reduced Models Are the Same to the Maximal Model
When all the reduced models are the same to the maximal model, it follows θ∗k = β
∗, XAk = X and gk = f
for k = 1, 2, . . . ,K. Then, for each k, uk(X;β∗, θ∗k) = uk(X;β
∗, β∗) =
∫
sk(y | XAk ;β∗)f(y | X;β∗)dy = ~0. By
the definition of ∆, we have ∆ = ~0. On the other hand, assuming EY |X{∇θksk(θ∗k)} = ∇θkEY |X{sk(θ∗k)} with
sk(θ
∗
k) = sk(Y | XAk ; θ∗k), it follows Λk = (1/ck)I(θ∗k), where I(θ∗k) is the Fisher’s information matrix of gk or f .
Then, the optimal C is
Copt = Λ
−1 = diag(c1Σ, . . . , cKΣ),
where Σ = I(θ∗k)
−1. Denote as Cˆopt a consistent estimator of Copt. Then, the GENMETA estimator with Cˆopt is
βˆopt = argminβU
T
n (β, θˆ)CˆoptUn(β, θˆ).
Under regularity conditions similar to those in Theorem 1, βˆopt → β∗ in probability. By Mean Value Theorem,
Un(βˆopt, θˆ) = Un(β
∗, θˆ) +Gn(β¯, θˆ)(βˆopt − β∗), (10)
where β¯ is the mean value and Gn(β¯, θˆ) = ∂Un(β, θˆ)/∂β |β=β¯ . By the first order condition, βˆopt satisfies
GTn (βˆopt, θˆ)CˆoptUn(βˆopt, θˆ) = 0. Left-multiplying (10) by GTn (βˆopt, θˆ)Cˆopt, it follows
βˆopt − β∗ = −{GTn (βˆopt, θˆ)Cˆopt ~Gn(β¯, θˆ)}−1{GTn (βˆopt, θˆ)CˆoptUn(β∗, θˆ)} (11)
Also,
Gn(βˆopt, θˆ) =
∂
∂β
~Un(β, θˆ) |β=βˆopt=

∂
∂βu1(β, θˆ1) |β=βˆopt
...
∂
∂βuK(β, θˆK) |β=βˆopt
 .
Under regularity conditions similar to those in Theorem 1, ∂uk(β, θˆk)/∂β |β=βˆopt= Σ−1 + op(1) for each k. Then,
Gn(βˆopt, θˆ) =
Σ
−1
...
Σ−1
+ op(1). (12)
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Similarly,
Gn(β¯, θˆ) =
Σ
−1
...
Σ−1
+ op(1). (13)
On the other hand, under regularity conditions similar to those in Theorem 1, uk(β∗, θˆk) = −Σ−1(θˆk−β)∗+op(1/n1/2).
Then,
Un(β
∗, θˆ) = −
Σ
−1(θˆ1 − β∗)
...
Σ−1(θˆK − β∗)
+ op(1/n1/2). (14)
Hence, by (11), (12), (13), (14) and Slutsky’s theorem,
βˆopt − β∗ =
( K∑
k=1
ck
)−1{ K∑
k=1
ck(θˆk − β∗)
}
+ op(1/n
1/2). (15)
On the other hand,
βˆmeta − β∗ =
{ K∑
k=1
( Σˆk
nk
)−1}−1{ K∑
k=1
( Σˆk
nk
)−1
θˆk
}
− β∗
=
( K∑
k=1
ck
)−1{ K∑
k=1
ck(θˆk − β∗)
}
+ op(1/n
1/2). (16)
Therefore, by (15) and (16), βˆopt = βˆmeta + op(1/n1/2).
A.2 Newton-Raphson’s Method and Iteratively Reweighted Least Squares Algo-
rithm
In this section we provide a derivation of the Newton-Raphson’s method for GENMETA with generalized linear
models. As in Section 2.3, we assume that the maximal and reduced models belong to the class of GLM (McCullagh
& Nelder, 1989). Specifically, assume the densities of Y | X and Y | XAk are of the forms
f(y | x;β, φ) = exp({1/a(φ)}(yh(xTβ)− b{h(xTβ)}) + c(y;φ)),
and
gk(y | xAk ; θk) = exp({1/a(φk)}(yh(xTAkθk)− b{h(xTAkθk)}) + c(y;φk)),
respectively, where a(·), b(·) and c(·) are known functions, h(·) = b′−1(g−1(·)), g is a monotone and differentiable
link function, and φ and φk are the dispersion parameters of the maximal and the kth reduced models, respectively.
Recall that we assume the maximal and the reduced models have the same link function g. However, both the
GENMETA and the Newton-Raphson’s method are flexible to allow the maximal and the reduced models to have
different link functions. We also assume ~X = ∪Kk=1 ~XAk , where the vectors of the covariates are viewed as sets
without confusion. Denote the dimensions of θk and β as dk and p, respectively. Assume d =
∑K
k=1 dk ≥ p since the
parameters of the maximal model will not be identifiable if d < p.
A.2.1 Case I : φ and φk’s are known.
The log-likelihood of gk is
lk(y | xAk ; θk) = {1/a(φk)}(yh(xTAkθk)− b{h(xTAkθk)}) + c(y;φk).
Then, the score function is
sk(y | xAk ; θk) = {1/a(φk)}{y − g−1(xTAkθk)}h′(xTAkθk)xAk .
Then,
uk(x;β, θk) = EY |Xsk{(y | xAk ; θk)} = {1/a(φk)}{g−1(xTβ)− g−1(xTAkθk)}h′(xTAkθk)xAk .
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Thus, the vector of empirical moment functions for β is
Un(β) = Pn

uk(X;β, θˆk)
uk(X;β, θˆk)
...
uk(X;β, θˆk)
 ,
where Pn is the empirical measure with respect to the reference sample.
Let Qn(β) = UTn (β)CUn(β) where ~C is a d × d positive definite matrix. The goal is to find the minimizer of
Qn(β). Its equivalent to solving the equation
Dn(β) = 0,
where Dn(β) = GTn (β)CUn(β) and Gn(β) = ∂Un(β)/∂β is a d × p matrix. Then, the tth iteration step for the
Newton-Raphson’s method is
β(t+1) = β(t) − Jn(β(t))−1Dn(β(t)), (17)
where Jn(β) = ∂Dn(β)/∂β is a p× p matrix.
Next, we write Dn(β) in a matrix form. The matrix form of Gn(β) is
Gn(β) = Pn
 [a(φ1)g
′{g−1(XTβ)}]−1h′(XTA1 θˆ1)XA1XT
...
[a(φK)g
′{g−1(XTβ)}]−1h′(XTAK θˆK)XAKXT
 = (1/n)XTAdiagWXrbind,
where Xrbind = 1 ⊗ X and X(n×p) is the reference data matrix; XAdiag = diag(XA1 , . . . , XAK ) and XAk(n×dk)
is the reference data matrix for the kth study; W = diag(W1, . . . ,WK), Wk = diag(wk1, . . . , wkn), wki =
[a(φk)g
′{g−1(XTi β)}]−1h′(XTAk,iθˆk) for k = 1, . . . ,K, i = 1, . . . , n and i, and XTi and XTAk,i are the ith rows
of X and XAk , respectively. Similarly, the matrix form of Un(β) is Un(β) = (1/n)XTAdiagr, where r = (r1, . . . , rK)
T ,
rk = (rk1, . . . , rkn)
T and rki = {1/a(φk)}{g−1(XTi β)− g−1(XTAk,iθˆAk,i)}h′(XTAk,iθˆAk,i) for each k and i. Thus, the
matrix form of Dn(β) is
Dn(β) = (1/n
2)XTrbindWXAdiagCX
T
Adiag
r. (18)
Next, we write Jn(β) in a matrix form. Let Gn(β) be partitioned by columns as Gn(β) = (Gn,1(β), . . . , Gn,p(β)),
where Gn,j(β) is a d× 1 column vector for j = 1, . . . , p. Then,
Jn(β) =
∂
∂β
Dn(β) =
∂
∂β
GTn (β)CUn(β)
=

∂
∂βG
T
n,1(β)CUn(β)
...
∂
∂βG
T
n,p(β)CUn(β)
 = GTn (β)CGn(β) +
U
T
n (β)C
∂
∂βGn,1(β)
...
UTn (β)C
∂
∂βGn,p(β)
 . (19)
Then, the matrix form of the first summand is (1/n2)XTrbindWXAdiagCX
T
Adiag
WXrbind. The jth row of the second
summand is rTXAdiagC∂Gn,j(β)/∂β. Note that
∂
∂β
Gn,j(β) = (1/n)X
T
Adiag
LX∗jdiagXrbind,
where L = diag(L1, . . . , LK), Lk = diag(lk1, . . . , lkn) and, for each k and i,
lki = −g′′{g−1(XTi β)}/(a(φk)[g′{g−1(XTi β)}]3h′(XTAk,iθˆk));
X∗jdiag = diag(Xjdiag , . . . , Xjdiag) with K diagonal blocks and Xjdiag = diag(X1j , . . . , Xnj) for j = 1, . . . , p. Then,
for each j, the matrix form of UTn (β)C∂Gn,j(β)/∂β is
(1/n2)rTXAdiagCX
T
Adiag
LX∗jdiagXrbind.
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Then, the second summand of (19) can be rewritten as (1/n2)XTrbindV Xrbind, where V = diag(v1, . . . , vnK) and vi
is the ith element of the row vector rTXAdiagCXTAdiagL. Thus,
Jn(β) = (1/n
2)XTrbind(WXAdiagCX
T
Adiag
W + V )Xrbind = (1/n
2)XTrbindW
∗Xrbind. (20)
where W ∗ = WXAdiagCXTAdiagW + V .
Therefore, plugging (18) and (20) in (17), we get the following tth iteration step
β(t+1) = β(t) − (XTrbindW ∗Xrbind)−1XTrbindWXAdiagCXTAdiagr,
which can be seen as the tth step of an iteratively reweighted least squares algorithm.
A.2.2 Case II : φ and φk’s are unknown.
When φ and φk’s are unknown, we propose to first obtain the GENMETA estimator βˆ of β? as above with φ′ks
replaced by φˆk’s. Next, let us consider the estimation of φ?, the true value of φ. For the kth reduced model, we
have an additional score function with respect to φk, which is
sk(y | xAk ; θk, φk) = −
a′(φk)
a2(φk)
(yh(xTAkθk)− b{h(xTAkθk)}) + c′(y;φk),
where c′(y;φk) is the derivative of c(y;φk) with respect to φk. Then, we obtain
uk(X;β, φ, θk, φk) = − a
′(φk)
a2(φk)
(g−1(XTβ)h(XTAkθk)− b{h(XTAkθk)}) + qk(X;β, φ, φk),
where qk = EY |X(c′(Y, φk)). The distribution of Y | X depends on β and φ so that qk also depends on them. Then,
the empirical moment vector for φ is
Un(φ) = Pn(u1(X; βˆ, φ, θˆ1, φˆ1)
T , . . . , uK(X; βˆ, φ, θˆK , φˆK)
T )T .
We propose to estimate φ? in the GMM framework. Thus, we need to compute the minimizer of Un(φ)TCUn(φ),
where C is a known weighting matrix. As before, we use the Newton-Raphson’s method and it can be written as
φ(t+1) = φ(t) − J−1n (φ(t))Dn(φ(t)), (21)
where
Jn(φ) = U
T
n (φ)C
d2
dφ2
qn(φ) + (
d
dφ
qn(φ))
TC
d
dφ
qn(φ),
Dn(φ) = U
T
n (φ
(t))Cdqn(φ)/dφ and ~qn(φ) = Pn(q1(X; βˆ, φ, φˆ1), . . . , qK(X; βˆ, φ, φˆK))T .
Thus, when φ and φk’s are unknown, we first choose initial estimates β(0) and φ(0). Then, we get the GENMETA
estimator βˆ by using equation (17) until a stopping rule is reached. Subsequently, φ(0), βˆ and the study estimates
are plugged in equation (21) and the process is repeated until a stopping rule is reached to get the GENMETA
estimator of φ∗. In each Newton-Raphson’s step, the weighting matrix C is estimated by the estimates from the
previous step.
If the estimates of the study dispersion parameters, φk’s, are not provided directly, but the the outcomes are
standardized (var(Y ) = 1), we can obtain them through the following relation based on conditional variance formula
a(φˆk) =
1− (Png−1(XTAk θˆk)2 − {Png−1(XTAk θˆk)}2)
Pnb′′{h(XTAk θˆk)}
,
where h(·) = b′−1(g−1(·)) and Pn is the empirical measure with the reference data. For normal family where the
canonical link is an identity function, we have b′′(ψ) = 1, which implies the denominator is 1.
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A.3 Full Proof of Theorem 1 and Checking Regularity Assumptions in Two Examples
We first provide a complete proof of Theorem 1 and then check the assumptions for logistic and linear regression
models.
Proof of Theorem 1. First, we show the consistency of βˆ. Denote θˆ and θ∗ as stacked vectors of θˆk’s and θ∗k’s,
respectively. Denote U0(β, θ) = E(U(X;β, θ)) and Q0(β) = U0(β, θ∗)TCU0(β, θ∗).
By (A1) and Lemma 2.3 of (Newey & McFadden, 1994), Q0(β) is uniquely minimized at β∗.
By (A2), (A3), (A4) and Lemma 2.4 of (Newey & McFadden, 1994), U0(β, θ) is continuous and Un(β, θ) converges
uniformly to U0(β, θ) for (β, θ) ∈ Dβ ×Nc(θ∗), where Nc(θ∗) is a compact subset of N(θ∗) including θ∗. Note that
θˆ is a consistent estimator of θ∗. With probability going to one (wpg1),
sup
β∈Dβ
||Un(β, θˆ)− U0(β, θˆ)|| ≤ sup
(β,θ)∈Dβ×Nc(θ∗)
||Un(β, θ)− U0(β, θ)||.
Then, Un(β, θˆ)− U0(β, θˆ) converges uniformly in probability to 0 for β ∈ Dβ .
For any r > 0, wpg1,
sup
β∈Dβ
||U0(β, θˆ)− U0(β, θ∗)|| ≤ sup
β∈Dβ
E( sup
||θ−θ∗||<r
||U(β, θ)− U(β, θ∗)||).
By (A3), (A4) and dominant convergence theorem, E(sup||θ−θ∗||<r ||U(β, θ)− U(β, θ∗)||) converges to 0 for every
β ∈ Dβ as r decreases to 0. Note that E(sup||θ−θ∗||<r ||U(β, θ)− U(β, θ∗)||) decreases as r decreases for each β. By
(A2) and Dini’s theorem (see, for example, Theorem 7.13 of (Rudin, 1976)), E(sup||θ−θ∗||<r ||U(β, θ)− U(β, θ∗)||)
converges uniformly in probability to 0 for β ∈ Dβ as r decreases to 0. Then, U0(β, θˆ) − U0(β, θ∗) converges
uniformly in probability to 0 for β ∈ Dβ .
By combining the above two results, it follows that Un(β, θˆ) converges uniformly in probability to U0(β, θ∗) for
β ∈ Dβ .
By the triangle and Cauchy-Schwartz inequalities,
sup
β∈Dβ
|Qn(β)−Q0(β)| ≤ ||Cˆ|| sup
β∈Dβ
||Un(β, θˆ)− U0(β, θ∗)||2
+ 2||Cˆ|| sup
β∈Dβ
||U0(β, θ∗)|| sup
β∈Dβ
||Un(β, θˆ)− U0(β, θ∗)||
+ ||Cˆ − C|| sup
β∈Dβ
||U0(β, θ∗)||2
Since Cˆ is a consistent estimator of C, ||Cˆ|| converges in probability to ||C||, which is finite; ||Cˆ − C|| converges
in probability to 0. Since U0(β, θ∗) is continuous for β ∈ Dβ and Dβ is compact, supβ∈Dβ ||U0(β, θ∗)||2 is finite.
Since supβ∈Dβ ||Un(β, θˆ)− U0(β, θ∗)|| converges in probability to 0, supβ∈Dβ ||Un(β, θˆ)− U0(β, θ∗)||2 converges in
probability to 0. Thus, Qn(β)−Q0(β) converges uniformly in probability to 0 for β ∈ Dβ . Recall that β∗ is the
unique minimizer of Q0(β). By Theorem 2.1 of (Newey & McFadden, 1994), βˆ is a consistent estimator of β∗.
Next, we derive the asymptotic distribution of the GENMETA estimator βˆ. Note that βˆ is a solution to
Gn(β, θˆ)
T CˆUn(β, θˆ) = 0,
where Gn(β, θˆ) = ∂Un(β, θˆ)/∂β, the Jacobian of Un(β, θˆ). On the other hand, by mean value theorem,
Un(βˆ, θˆ) = Un(β
∗, θˆ) +Gn(β¯, θˆ)(βˆ − β∗),
where β¯ denotes a matrix each column of which corresponds to each element of Un(β, θˆ). After left multiplying
Gn(βˆ, θˆ)
T Cˆ to the above identity, it follows
n1/2(βˆ − β∗) = −Mnn1/2Un(β∗, θˆ),
where Mn = (Gn(βˆ, θˆ)T CˆGn(β¯, θˆ))−1Gn(βˆ, θˆ)T Cˆ.
Consider Mn. Since βˆ is a consistent estimator of β∗, each column of β¯ is a consistent estimator of β∗. On
the other hand, θˆ is a consistent estimator of θ∗. By (A5), (A6) and Lemma 2.4 of (Newey & McFadden, 1994),
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Gn(β, θ) converge uniformly to continuous E{∂U(X;β, θ)/∂β} for (β, θ) ∈ Dβ ×Nc(θ∗), where Nc(θ∗) is a compact
subset of N(θ∗), including θ∗. Since βˆ and each column of β¯ converge in probability to β∗ and θˆ is a consistent
estimator of θ∗, by, for example, Theorem 9.4 of (Keener, 2010), both Gn(βˆ, θˆ) and Gn(β¯, θˆ) converges in probability
to Γ = E{∂U(X;β∗, θ∗)/∂β}. Thus, by noting Cˆ→C in probability, Mn converges in probability to (ΓTCΓ)−1ΓTC.
Consider n1/2Un(β∗, θˆ). By mean value theorem,
Un(β
∗, θˆ) = Un(β∗, θ∗) + Vn(β∗, θ¯)(θˆ − θ∗),
where Vn is the Jacobian of Un(β∗, θ) as a function of θ and θ¯ is a matrix each column of which corresponds to each
element of Un(β∗, θ). Thus,
n1/2Un(β
∗, θˆ) = n1/2Un(β∗, θ∗) + Vn(β∗, θ¯)n1/2(θˆ − θ∗).
By (A9) and central limit theorem, n1/2Un(β∗, θ∗)
d→ N(0,∆). Since θˆ is a consistent estimator of θ∗. each column of
θ¯ converges in probability to θ∗. Similar to the above argument, by (A7), (A8), Lemma 2.4 of (Newey & McFadden,
1994) and Theorem 9.4 of (Keener, 2010),
Vn(β
∗, θ¯)→diag(W1,W2, . . . ,WK) in probability,
where, for k = 1, 2, . . . ,K, Wk = E{∂uk(X,β∗, θk)/∂θk} |θk=θ∗k . The K study data sets are independent. So are
θˆk’s. Note that nk/n → ck, where ck is a positive constant for k = 1, 2, . . . ,K. Then n1/2(θˆ − θ∗) converges in
distribution to
N(0, diag((1/c1)Σ1, (1/c2)Σ2, . . . , (1/cK)ΣK)).
Since the K data sets and the reference data are independent, the above results imply that n1/2Un(β∗, θˆ) converges in
distribution to N(0,∆ + Λ), where Λ is a block diagonal matrix whose kth block is (1/ck)WkΣkWTk for k = 1, . . . ,K.
Therefore, with the above two results on Mn and n1/2Un(β∗, θˆ) and by Slutsky’s theorem, the asymptotic
normality of n1/2(βˆ − β∗) follows.
Example A.1 (Check Assumptions for Logistic Regression Model). Suppose the maximal model is
Y | X ∼ Bernoulli
{ 1
1 + exp(−XTβ∗)
}
,
where X = (1, XT )T , X = (X1, . . . , Xd)T is the vector of covariates and β∗ = (β∗0 , β∗1 , . . . , β∗p)T is the vector of
coefficients of interest. There are K independent studies and the reduced model of the kth study is
Y | XAk ∼ Bernoulli
{ 1
1 + exp(−XTAkθk)
}
,
where XAk = (1, XTAk)
T , XAk is a sub-vector of X with A ⊂ {1, 2, . . . , p}. For example, XA = (X1, X2)T when
A = {1, 2}.
The global identification assumption (A1) usually holds and Dβ is a compact set. Next, we check the assumptions
(A3) to (A9). The moment functions from the kth study is
uk(X;β, θk) =
( 1
1 + e−XT β
− 1
1 + e
−XTAkθk
)
XAk .
It is a continuous function of β and θk. Then, (A3) is satisfied. Note that
sup
(β,θ)∈Dβ×N(θ∗)
||
( 1
1 + e−XT β
− 1
1 + e
−XTAkθk
)
XAk || ≤ 2||X||1,
where || · || and || · ||1 are the l2 and l1 norms, respectively. Then, given E(|Xi|) <∞ for each i, (A4) is satisfied.
Also,
∂
∂β
uk(X;β, θk) =
e−X
T β
(1 + e−XT β)2
XAkX
T , (22)
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which does not depend on θk and is continuous for each β. Then, (A5) is verified. Note that
sup
(β,θ)∈Dβ×N(θ∗)
|| e
−XT β
(1 + e−XT β)2
XAkX
T || ≤ ||XXT ||1.
Given E(X2i ) <∞ for each i, (A6) is satisfied. Note that
∂
∂θk
uk(X;β
∗, θk) = − e
−XTAkθk
(1 + e
−XTAkθk)2
XAkX
T
Ak
,
which is continuous for each θk. Then, (A7) is satisfied. Note that
sup
(β,θ)∈Dβ×N(θ∗)
|| − e
−XTAkθk
(1 + e
−XTAkθk)2
XAkX
T
Ak
|| ≤ ||XXT ||1.
Given E(X2i ) < ∞ for each i, (A8) is satisfied. The absolute value of each element of ∆(β∗, θ∗) is less than 1,
E(|Xi|) or E(|XiXj |) for each i and j. Given E(X2i ) < ∞, ∆(β∗, θ∗) is finite. Note that Γ(β∗, θ∗k) is a stacked
matrix of (22) for k = 1, . . . ,K. Given each covariate of the maximal model is in at least one reduced model and
E[{e−XT β/(1 + e−XT β)2}XXT ] is positive definite, Γ(β∗, θ∗) is of full rank. Then, (A9) is verified.
Example A.2 (Check Assumptions for Linear Regression Model). Suppose the true maximal model is
Y | X ∼ N(XTβ∗, σ∗2),
where X = (X1, X2, . . . , Xp)T ; β∗ = (β∗1 , β∗2 , . . . , β∗p)T ; E(X) = 0 and E(Y ) = 0, that is, both X and Y are centered.
There are K independent studies and the reduced model of the kth study is
Y | XAk ∼ N(XTAkθk, σ2k).
For simplicity, assume σ∗2 is known and the unknown parameter is β∗. The case with unknown σ∗2 can be similarly
considered.
The moment functions from the kth reduced model is
uk(X;β; θk, σ
2
k) =
1
σ2k
(XAkX
Tβ −XAkXTAkθk),
which is linear in β. Note that
∂
∂β
uk(X;β; θk, σ
2
k) =
1
σ2k
XAkX
T . (23)
Given each covariate of the maximal model is in at least one reduced model and E(XXT ) is positive definite,
Γ(β∗, {θ∗k}, {σ∗2k }) = ∂uk(X;β∗; {θ∗k}, {σ∗2k })/∂β is of full rank. Given C is positive definite, (A1) is satisfied.
Suppose Dβ is a compact set. Then, (A2) is satisfied.
Next, we check the assumptions (A3) to (A9). Note that uk(X;β; θk, σ2k) is continuous for every (β, θk, σ
2
k).
Then, (A3) is satisfied. Note that
sup
(β,θk,σ2k)
|| 1
σ2k
(XAkX
Tβ −XAkXTAkθk)|| ≤
1
σ2k
(||β||+ ||θk||)||XXT ||1,
Denote a finite upper bound of ||β|| for β ∈ Dβ as C(β), a finite upper bound of ||θk|| for θk ∈ N(θ∗k) as
C(θk), and a positive finite lower bound of σ2k for σ
2
k ∈ N(θ∗k) as σ2L. The supremum of (1/σ2k)(||β|| + ||θk||) for
(β, θk, σ
2
k) ∈ Dβ × N(θ∗k) × N(σ∗2k ) is bounded by (1/σ2L)(C(β) + C(θk)). Given E(X2i ) < ∞ for each i, (A4) is
satisfied. Note that ∂uk(X;β; θk, σ2k)/∂β does not depend on β and θk and is continuous for each σ
2
k. Then, (A5) is
satisfied. Note that
sup
σ2k∈N(σ∗2k )
|| 1
σ2k
XAkX
T || ≤ 1
σ2L
||XXT ||1.
Given E(X2i ) <∞ for each i, (A6) is satisfied. Note that
∂
∂(θk, σ2k)
uk(X;β; θk, σ
2
k) = {−
1
σ2k
XAkX
T
Ak
,− 1
σ4k
(XAkX
Tβ −XAkXTAkθk)},
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which is continuous for every (β, θk, σ2k). Then, (A7) is satisfied. For every (β, θk, σ
2
k) ∈ Dβ ×N(θ∗k, N(σ∗2k )), the l2
norm of the above partial derivative is less than or equal to
1
σ2L
+
1
σ4L
(C(β) + C(θk))||XXT ||1.
Given E(X2i ) < ∞ for each i, (A8) is satisfied. Each element of ∆(β∗, {θ∗k}, {σ∗2k }) is equal to a constant times
E(Xi1Xi2Xi3Xi4) for some i1, i2, i3, i4. Given E(X4i ) <∞ for each i, ∆ is finite. Note that Γ(β∗, {θ∗k}, {σ∗2k }) is a
stacked matrix of (23) for k = 1, . . . ,K. As in checking (A2), given each covariate of the maximal model is in at
least one reduced model and E(XXT ) is positive definite, Γ is of full rank. Then, (A9) is verified.
A.4 Simulation Results for Log-normally Distributed Covariates
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Table S1: Robustness of GENMETA Estimation (Log-normally Distributed Covariates)
Setting Study-I Study-II Study-III Reference β∗i Bias SD (ESD) RMSE CR AL
µb µb µb µb β
∗
1 .010 .076 (.075) .077 .941 .288
I σ2b σ
2
b σ
2
b σ
2
b β
∗
2 .011 .064 (.061) .065 .947 .237
ρb ρb ρb ρb β
∗
3 .006 .066 (.064) .066 .954 .246
µb µh µm µb β
∗
1 .010 .079 (.072) .079 .930 .272
σ2b σ
2
b σ
2
b σ
2
b β
∗
2 .002 .056 (.054) .056 .948 .211
ρb ρb ρb ρb β
∗
3 -.002 .062 (.058) .062 .945 .222
µb µb µb µb β
∗
1 .032 .088 (.088) .094 .930 .339
II σ2b σ
2
h σ
2
l σ
2
b β
∗
2 -.002 .062 (.057) .062 .941 .221
ρb ρb ρb ρb β
∗
3 -.005 .074 (.074) .074 .967 .286
µb µh µm µb β
∗
1 .021 .079 (.077) .081 .929 .294
σ2b σ
2
h σ
2
l σ
2
b β
∗
2 .0005 .055 (.055) .055 .956 .213
ρb ρb ρb ρb β
∗
3 -.008 .065 (.064) .065 .954 .246
µb µb µb µb β
∗
1 -.062 .107 (.118) .124 .934 .382
σ2b σ
2
b σ
2
b σ
2
b β
∗
2 .021 .070 (.065) .073 .930 .250
ρb ρb ρb ρh β
∗
3 .030 .087 (.096) .092 .956 .322
µb µb µb µb β
∗
1 .039 .072 (.069) .081 .891 .264
σ2b σ
2
b σ
2
b σ
2
b β
∗
2 .023 .065 (.062) .069 .932 .240
ρb ρb ρb ρl β
∗
3 .018 .061 (.058) .064 .930 .224
µb µb µb µb β
∗
1 .053 .079 (.075) .095 .866 .290
III σ2b σ
2
b σ
2
b σ
2
b β
∗
2 .019 .065 (.063) .067 .942 .242
ρl ρb ρh ρl β
∗
3 .012 .068 (.064) .069 .935 .249
µb µb µb µb β
∗
1 .032 .089 (.084) .095 .912 .322
σ2b σ
2
b σ
2
b σ
2
b β
∗
2 .010 .062 (.062) .063 .946 .240
ρl ρb ρh ρb β
∗
3 -.009 .073 (.071) .073 .942 .273
µb µb µb µb β
∗
1 -.025 .113 (.108) .116 .954 .407
σ2b σ
2
b σ
2
b σ
2
b β
∗
2 .017 .065 (.064) .067 .951 .248
ρl ρb ρh ρh β
∗
3 -.002 .091 (.091) .091 .965 .347
µb µb β
∗
1 .007 .096 (.104) .096 .968 .365
IV X1 > −0.5, X2 > 0 σ2b σ2b β∗2 .242 .353 (.117) .428 .572 .401
X2 < 0.5 ρb ρb β
∗
3 -.015 .067 (.081) .068 .971 .283
Biases, standard deviation (SD), estimated standard deviation (ESD), square roots of mean square errors
(RMSE), coverage rates (CR), and average lengths (AL) of 95% confidence intervals of the GENMETA es-
timates using the study covariance estimators in the setting of logistic regression. In setting (I), data are
simulated in ideal setting where the covariate distribution is a log-normal distribution with the natural loga-
rithm of the covariates being characterized by mean, sd and correlation of normal variates and are assumed
to same across all populations. In setting (II)-(IV), the assumption is violated by creating variations in
mean/sd, correlations of the underlying normal distribution and selection criterion across the studies and
reference sample. The vector of means, variances and correlations of the underlying normal covariates are
denoted by µ∗ = (µ1, µ2, µ3), σ2∗ = (σ21 , σ22 , σ23) and ρ∗ = (ρ12, ρ23, ρ13) for ∗ ∈ {b, l,m, h}, where µb = (0, 0, 0),
µm = (0.5, 0.5, 0.5), µh = (1, 1, 1); σ2b = (1, 1, 1), σ
2
l = (0.5, 0.5, 0.5), σ
2
h = (2, 2, 2) and ρb = (0.3, 0.6, 0.1),
ρh = (0.4, 0.8, 0.2), ρl = (0.2, 0.4, 0). Estimated standard deviation are obtained by the asymptotic formula (2)
in the main paper and used to construct 95% confidence interval.
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